← All companies

VRDN

Viridian Therapeutics, Inc.

VRDN Nasdaq Pharmaceutical Preparations EDGAR ↗

$19.31

-0.59 -2.96%

Key statistics

from XBRL data in SEC filings

Market cap

$1.99B

Revenue (TTM)

$70.9M

Net income (TTM)

-$361M

EPS (TTM)

$-4.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$277M

Cash

$176M

Total assets

$789M

Gross margin

—

52-week range

$13.18 – $34.29

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jun 29, 2026 8-K Shareholder vote results Jun 3, 2026 8-K Terminated a material agreement May 28, 2026 8-K Entered a material agreement May 26, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events May 11, 2026 8-K Regulation FD disclosure May 5, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Regulation FD disclosure Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement Oct 23, 2025 8-K Results of operations (earnings release) Oct 21, 2025 8-K Entered a material agreement Oct 20, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 30, 2025 8-K Director or officer change; Shareholder vote results Jun 24, 2025 8-K Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Director or officer change; Regulation FD disclosure Apr 7, 2025 8-K Director or officer change Mar 10, 2025 8-K Entered a material agreement; Terminated a material agreement Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Director or officer change Jan 10, 2025 8-K Regulation FD disclosure; Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 8-K Entered a material agreement Sep 12, 2024 8-K Regulation FD disclosure; Other events Sep 10, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Regulation FD disclosure Jul 15, 2024 8-K Director or officer change; Shareholder vote results Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024